Your session is about to expire
← Back to Search
Whole Blood Transfusion for Trauma Patients
Phase 3
Waitlist Available
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult male patients brought into the emergency department as LEVEL A trauma activations who are receiving emergency blood transfusions
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours post ed admission
Awards & highlights
Study Summary
This trial is looking at whether or not adult male patients who are brought to the emergency department as Level A trauma activations and are receiving emergency blood transfusion benefit from receiving more blood.
Eligible Conditions
- Acute Blood Loss Anemia
- Hemorrhagic Shock
- Traumatic Brain Injury
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
Adult men brought to the emergency room as severe trauma cases and receiving emergency blood transfusions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours post ed admission
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post ed admission
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
pRBC equivalents transfused
Secondary outcome measures
Mortality
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Low Titer O+ Whole BloodExperimental Treatment1 Intervention
Low Titer O+ Whole blood provided to Level A trauma patients
Group II: Component TherapyActive Control1 Intervention
Component Therapy of O+ pRBC and FFP dispatched to trauma bay for level A traumas
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Routine labs
2022
Completed Phase 3
~210
Find a Location
Who is running the clinical trial?
Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,787 Total Patients Enrolled
1 Trials studying Anemia
299 Patients Enrolled for Anemia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Patients who were declared dead upon arrival to the trauma bay.Adult men brought to the emergency room as severe trauma cases and receiving emergency blood transfusions.
Research Study Groups:
This trial has the following groups:- Group 1: Low Titer O+ Whole Blood
- Group 2: Component Therapy
Awards:
This trial has 2 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any enrolment opportunities for this experiment?
"Confirmed. The information on clinicaltrials.gov depicts that this study, which was initially published on March 5th 2022, is currently seeking out suitable participants. Approximately 200 volunteers need to be recruited from 1 medical centre."
Answered by AI
How many volunteers have enrolled in this research project?
"Affirmative. Information hosted on clinicaltrials.gov verifies that this medical trial, which was initially posted on March 5th 2022, is currently recruiting participants. Approximately 200 subjects need to be enrolled from 1 health facility."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger